News

Modified budget table: DIGITAL-2022-CLOUD-AI-03 and DIGITAL-ECCC-2022-CYBER-03

Published on | 3 years ago

Programmes
AI Continent Cybersecurity

The European Commission has made changes to the budget table for calls DIGITAL-2022-CLOUD-AI-03 (deadline 24 January 2023) and DIGITAL-ECCC-2022-CYBER-03 (deadline 15 February 2023):

The budget table relating to this call has been modified ONLY for those topics where the cost category of Financial support to third parties is not an eligible cost. 

Please make sure to check the call document to see whether this cost category is eligible under your topic or not. Those topics for which “Financial support to third parties” is not an eligible cost are affected by the removal of the column relating to this cost category in the budget table. Should your topic not allow for this cost category (as per call document), and should you have included an amount under this column, we would recommend that you revise your budget table.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1842 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.